Fresh2 (FRES) had the best month in January 2020 by a US stock in January 2020, returning 3,594,926.6%.

ASSET	MONTH	% RETURN
Fresh2 (FRES)	January 2020	3,594,926.64%
Kaival Brands Innovations (KAVL)	January 2020	13,760%
Ainos (AIMD)	January 2020	6,150%
Newegg Commerce (NEGG)	January 2020	731.43%
Mediaco (MDIA)	January 2020	557%
NanoViricides (NNVC)	January 2020	523.05%
Genprex (GNPX)	January 2020	432.35%
Aethlon Medical (AEMD)	January 2020	347.42%
Vaxart (VXRT)	January 2020	273.13%
Co-Diagnostics (CODX)	January 2020	262.22%
Viridian Therapeutics (VRDN)	January 2020	253.25%
Adaptimmune Therapeutics (ADAP)	January 2020	219.67%
Nixxy (NIXX)	January 2020	168.18%
NFT (MI)	January 2020	168.13%
Reliance Global (RELI)	January 2020	147.05%
Catheter Precision (VTAK)	January 2020	124.55%
American Lithium Corp Common Stock (AMLI)	January 2020	120.65%
Clean Energy Technologies, Inc Common Stock (CETY)	January 2020	114.58%
Vir Biotechnology (VIR)	January 2020	112.02%
Future Fintech (FTFT)	January 2020	102.81%
Briacell Therapeutics (BCTX)	January 2020	98.25%
Protara Therapeutics (TARA)	January 2020	98.18%
China Pharma (CPHI)	January 2020	95.13%
Yunhong Green CTI (YHGJ)	January 2020	94.12%
Applied Therapeutics (APLT)	January 2020	92.2%